These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15368498)

  • 1. Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia.
    van der Vleuten GM; Hijmans A; Kluijtmans LA; Blom HJ; Stalenhoef AF; de Graaf J
    Am J Med Genet A; 2004 Sep; 130A(1):73-5. PubMed ID: 15368498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
    Coon H; Singh N; Dunn D; Eckfeldt JH; Province MA; Hopkins PN; Weiss R; Hunt SC; Leppert MF;
    Atherosclerosis; 2004 Jun; 174(2):357-62. PubMed ID: 15136067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positional cloning of the combined hyperlipidemia gene Hyplip1.
    Bodnar JS; Chatterjee A; Castellani LW; Ross DA; Ohmen J; Cavalcoli J; Wu C; Dains KM; Catanese J; Chu M; Sheth SS; Charugundla K; Demant P; West DB; de Jong P; Lusis AJ
    Nat Genet; 2002 Jan; 30(1):110-6. PubMed ID: 11753387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH).
    Schäffler A; Orsó E; Palitzsch KD; Büchler C; Drobnik W; Fürst A; Schölmerich J; Schmitz G
    Biochem Biophys Res Commun; 1999 Jul; 260(2):416-25. PubMed ID: 10403784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
    Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
    Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Hijmans A; van Duijn CM; Stalenhoef AF; de Graaf J
    J Lipid Res; 2007 Jan; 48(1):193-200. PubMed ID: 17065663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
    Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein phenotype and insulin resistance in familial combined hyperlipidemia.
    Ascaso JF; Real JT; Merchante A; Rodrigo A; Carmena R
    Metabolism; 2000 Dec; 49(12):1627-31. PubMed ID: 11145128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?
    van der Vleuten GM; Hijmans A; Heil S; Blom HJ; Stalenhoef AF; de Graaf J
    Am J Med Genet A; 2006 May; 140(9):1010-2. PubMed ID: 16575890
    [No Abstract]   [Full Text] [Related]  

  • 11. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
    Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
    J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of insulin resistance in familial combined hyperlipidemia.
    Veerkamp MJ; de Graaf J; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
    van Himbergen TM; van Tits LJ; Ter Avest E; Roest M; Voorbij HA; de Graaf J; Stalenhoef AF
    Atherosclerosis; 2008 Jul; 199(1):87-94. PubMed ID: 18096166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial combined hyperlipidaemia: under - defined and under - diagnosed?
    Wierzbicki AS; Graham CA; Young IS; Nicholls DP
    Curr Vasc Pharmacol; 2008 Jan; 6(1):13-22. PubMed ID: 18220935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
    Bredie SJ; van Drongelen J; Kiemeney LA; Demacker PN; Beaty TH; Stalenhoef AF
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):834-40. PubMed ID: 9157945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locus for elevated apolipoprotein B levels on chromosome 1p31 in families with familial combined hyperlipidemia.
    Allayee H; Krass KL; Pajukanta P; Cantor RM; van der Kallen CJ; Mar R; Rotter JI; de Bruin TW; Peltonen L; Lusis AJ
    Circ Res; 2002 May; 90(8):926-31. PubMed ID: 11988495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
    Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
    Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
    Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
    J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia.
    Reymer PW; Groenemeyer BE; Gagné E; Miao L; Appelman EE; Seidel JC; Kromhout D; Bijvoet SM; van de Oever K; Bruin T
    Hum Mol Genet; 1995 Sep; 4(9):1543-9. PubMed ID: 8541837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.